118 related articles for article (PubMed ID: 10651125)
1. Splenic lymphoma with villous lymphocytes: dissociated response with fludarabin.
Tchiknavorian X; Otto J; Pivot X; Arnaud MC; Schneider M; Thyss A
Hematol Cell Ther; 1999 Nov; 41(5):233-4. PubMed ID: 10651125
[No Abstract] [Full Text] [Related]
2. Fludarabine therapy in patients with splenic lymphoma with villous lymphocytes: an update.
Lefrère F; Lévy V; François S; Delarue R; Ifrah N; Tilly H; Valensi F; Troussard X; Varet B; Hermine O
Leukemia; 2004 Nov; 18(11):1924-5. PubMed ID: 15385943
[No Abstract] [Full Text] [Related]
3. Dramatic efficacy of fludarabine in the treatment of an aggressive case of splenic lymphoma with villous lymphocytes.
Yasukawa M; Yamauchi H; Azuma T; Takada K; Ishimura M; Fujita S
Eur J Haematol; 2002 Aug; 69(2):112-4. PubMed ID: 12366716
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine is effective in the treatment of splenic lymphoma with villous lymphocytes.
Bolam S; Orchard J; Oscier D
Br J Haematol; 1997 Oct; 99(1):158-61. PubMed ID: 9359516
[TBL] [Abstract][Full Text] [Related]
5. [Successful treatment of splenic lymphoma with villous lymphocytes by rituximab and laparoscopic splenectomy].
Fujita T; Asagoe K; Sakoda H
Rinsho Ketsueki; 2003 Apr; 44(4):249-53. PubMed ID: 12784658
[TBL] [Abstract][Full Text] [Related]
6. Splenic lymphoma with villous lymphocytes: natural history and response to therapy in 50 cases.
Mulligan SP; Matutes E; Dearden C; Catovsky D
Br J Haematol; 1991 Jun; 78(2):206-9. PubMed ID: 2064958
[TBL] [Abstract][Full Text] [Related]
7. [Beneficial effect of interferon alfa-2a in a case of splenic lymphoma with circulating villous cells].
Ferrer Marco R; Ruiz Guinaldo MA; Martínez Martínez J; Navarro Gonzalo I
Sangre (Barc); 1993 Dec; 38(6):503-4. PubMed ID: 8171390
[No Abstract] [Full Text] [Related]
8. Fludarabine: an effective treatment in patients with splenic lymphoma with villous lymphocytes.
Lefrère F; Hermine O; Belanger C; François S; Tilly H; Lebas de La Cour JC; Valensi F; Varet B; Troussard X
Leukemia; 2000 Apr; 14(4):573-5. PubMed ID: 10764141
[TBL] [Abstract][Full Text] [Related]
9. Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients.
Parry-Jones N; Matutes E; Gruszka-Westwood AM; Swansbury GJ; Wotherspoon AC; Catovsky D
Br J Haematol; 2003 Mar; 120(5):759-64. PubMed ID: 12614206
[TBL] [Abstract][Full Text] [Related]
10. Severe T-mediated bone marrow aplasia in a patient with splenic lymphoma with villous lymphocytes (SLVL) previously treated with fludarabine regimen.
Rocco S; Improta S; Sagristani M; Quirino AA; Nitrato Izzo G; Russolillo S; Polistina MT; Mastrullo L
Haematologica; 2004 Jun; 89(6 Suppl):ECR19. PubMed ID: 15194555
[No Abstract] [Full Text] [Related]
11. Splenic lymphoma with villous lymphocytes (SLVL) responding to 2-chlorodeoxyadenosine (2-CdA).
Virchis A; Mehta A
Br J Haematol; 1998 Mar; 100(3):609. PubMed ID: 9504654
[No Abstract] [Full Text] [Related]
12. The role of splenectomy in splenic marginal zone B-cell lymphoma.
Marti GE
Clin Lymphoma; 2002 Jun; 3(1):48. PubMed ID: 12141955
[No Abstract] [Full Text] [Related]
13. Splenic marginal zone lymphoma with and without villous lymphocytes.
Matutes E
Curr Treat Options Oncol; 2007 Apr; 8(2):109-16. PubMed ID: 17680218
[TBL] [Abstract][Full Text] [Related]
14. [Splenic marginal zone lymphoma associated with autoimmune hemolytic anemia treated with splenectomy and rituximab].
Miztani M; Noda T; Umino A; Tanigawa M; Taniguchi M; Tamaki S; Tsuji K
Rinsho Ketsueki; 2007 Nov; 48(11):1489-91. PubMed ID: 18080507
[TBL] [Abstract][Full Text] [Related]
15. Management of non-Hodgkin's lymphoma.
Pitney WR; Robilliard JF
Med J Aust; 1974 Jul; 2(3):99-102. PubMed ID: 4606781
[No Abstract] [Full Text] [Related]
16. Treatment of splenic marginal zone lymphoma: splenectomy versus rituximab.
Bennett M; Schechter GP
Semin Hematol; 2010 Apr; 47(2):143-7. PubMed ID: 20350661
[TBL] [Abstract][Full Text] [Related]
17. p53 abnormalities in splenic lymphoma with villous lymphocytes.
Gruszka-Westwood AM; Hamoudi RA; Matutes E; Tuset E; Catovsky D
Blood; 2001 Jun; 97(11):3552-8. PubMed ID: 11369650
[TBL] [Abstract][Full Text] [Related]
18. [Primary lymphoma of the spleen: clinical analysis of 23 cases].
Zhang R; Wang D; Li Q; Sun T; Hao X
Zhonghua Wai Ke Za Zhi; 2002 Mar; 40(3):208-9. PubMed ID: 11955418
[TBL] [Abstract][Full Text] [Related]
19. Rituximab monotherapy for splenic marginal zone lymphoma with villous lymphocytes: report on long-term disease control for two patients with recurrence after splenectomy.
Debiasi M; Hehnemann M; Garicochea B
Sao Paulo Med J; 2010 Dec; 128(6):375-7. PubMed ID: 21308163
[TBL] [Abstract][Full Text] [Related]
20. Outline for writing an article for current treatment options in oncology: splenic lymphoma with villous lymphocytes.
Troussard X; Cornet E
Curr Treat Options Oncol; 2007 Apr; 8(2):97-108. PubMed ID: 17634839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
